SBI Securities’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622 Buy
107
+50
+88% +$332 ﹤0.01% 2969
2026
Q1
$413 Sell
57
-3
-5% -$39 ﹤0.01% 2964
2025
Q4
$1.02K Sell
60
-45
-43% -$457 ﹤0.01% 2637
2025
Q3
$769 Buy
105
+31
+42% +$251 ﹤0.01% 2800
2025
Q2
$481 Hold
74
﹤0.01% 2985
2025
Q1
$598 Buy
74
+5
+7% +$55 ﹤0.01% 2796
2024
Q4
$854 Buy
+69
New +$921 ﹤0.01% 2681

Other funds holding WVE

SBI Securities's WVE Position: Q2 2026 in Review

SBI Securities increased its Wave Life Sciences (WVE) stake by 88% in Q2 2026, buying an estimated $332 and bringing the position to 107 shares worth $622. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

SBI Securities first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.02K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • SBI Securities held 107 shares of Wave Life Sciences worth $622 as of Q2 2026.
  • SBI Securities bought 50 Wave Life Sciences shares in Q2 2026, an estimated $332.
  • Wave Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2969 holding.
  • SBI Securities first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Wave Life Sciences position peaked at $1.02K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.